Global Obesity Management Market to Reach USD 3,494.5 Million by 2033, Growing at a CAGR of 5.2%

Global Obesity Management Market
Global Obesity Management Market

The global obesity management market is set for steady growth over the next decade, with a projected compound annual growth rate (CAGR) of 5.2% from 2023 to 2033. Valued at approximately USD 2,095.6 million in 2023, the market is anticipated to reach USD 3,494.5 million by 2033, according to recent industry analysis.

This growth is largely driven by increasing obesity rates worldwide, along with rising awareness and demand for effective weight management solutions. The market includes a diverse array of products and services, including pharmacological treatments, lifestyle intervention programs, and surgical solutions. Technological advancements in non-invasive procedures and digital health tools, such as mobile applications and wearables, are further contributing to the expansion of the obesity management market.

The increasing prevalence of obesity-related health conditions, including diabetes, cardiovascular disease, and hypertension, underscores the need for effective management solutions, which is creating a positive growth environment. North America currently leads the global market, while regions such as Asia-Pacific are expected to experience accelerated growth due to rising health awareness and government initiatives addressing obesity.

Due to the steep rise in obesity prevalence over the last two decades, the global market is expected to generate significant revenue in the future. The key factors expected to drive the market are:

  • An increase in the obese population
  • An increase in the number of bariatric surgeries
  • An increase in the adoption of online weight loss and weight management programs
  • An increase in disposable income in developing economies
  • Sedentary lifestyle
  • Increased government initiatives to raise awareness among the obese population

Key Players Profiled in the Global Market

  • GlaxoSmithKline Plc.
  • VIVUS, Inc.
  • Novo Nordisk A/S
  • Currax Pharmaceuticals LLC
  • Cheplapharm Arzneimittel GmbH
  • Bausch Health Companies Inc.
  • Takeda Pharmaceuticals, Inc.

A Detailed Full Report

Key Segmentation

By Drug Type:

  • Bupropion and Naltrexone
  • Orlistat
  • Lorcaserin
  • Phentermine and Topiramate
  • Liraglutide

By Surgery Type:

  • Gastric Bypass Surgery
  • Adjustable Gastric Banding Surgery
  • Gastric Sleeve Surgery
  • Duodenal Switch Surgery
  • Others

By Distribution Channel:

  • Hospitals Pharmacies
  • Retail Pharmacies
  • E-commerce

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • The Middle East & Africa (MEA)
  • Europe

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Leave a comment

Your email address will not be published. Required fields are marked *